Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients with Hyperkalaemia

Trial Identifier: D9480C00014
Sponsor: AstraZeneca
NCTID:: NCT04997161
Start Date: August 2021
Primary Completion Date: November 2021
Study Completion Date: November 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
GB Bradford, GB, BD9 6RJ
GB Hull, GB, HU32JZ
GB Leicester, GB, LE1 5WW
GB LONDON, GB, E1 1BB
GB Manchester, GB, M13 9WL
GB York, GB, YO31 8HE
US, CA Torrance, CA, US, 90502
US, CA Victorville, CA, US, 92394
US, CT Hartford, CT, US, 06112
US, CT Middlebury, CT, US, 06762
US, FL Lauderdale Lakes, FL, US, 33313
US, FL West Palm Beach, FL, US, 33411
US, MA Springfield, MA, US, 01107
US, NV Las Vegas, NV, US, 89128
US, NY Bronx, NY, US, 10461
US, TN Knoxville, TN, US, 37923
US, TX Conroe, TX, US, 77384
US, TX El Paso, TX, US, 79936
US, TX Houston, TX, US, 77054
US, TX Houston, TX, US, 77004
US, TX San Antonio, TX, US, 78251
US, VA Norfolk, VA, US, 23502
US, WI Milwaukee, WI, US, 53226